Source: Tropical Medicine and International Health. Unidade: FOB
Subjects: HANSENÍASE (TRATAMENTO), MYCOBACTERIUM LEPRAE, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, E. A. et al. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions. Tropical Medicine and International Health, v. 12, n. 12, p. 1450-1458, 2007Tradução . . Disponível em: https://doi.org/10.1111/j.1365-3156.2007.01951.x. Acesso em: 16 nov. 2024.APA
Silva, E. A., Iyer, A., Ura, S., Lauris, J. R. P., Naafs, P. K., Das, P. K., & Vilani-Moreno, F. (2007). Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions. Tropical Medicine and International Health, 12( 12), 1450-1458. doi:10.1111/j.1365-3156.2007.01951.xNLM
Silva EA, Iyer A, Ura S, Lauris JRP, Naafs PK, Das PK, Vilani-Moreno F. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions [Internet]. Tropical Medicine and International Health. 2007 ; 12( 12): 1450-1458.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1365-3156.2007.01951.xVancouver
Silva EA, Iyer A, Ura S, Lauris JRP, Naafs PK, Das PK, Vilani-Moreno F. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions [Internet]. Tropical Medicine and International Health. 2007 ; 12( 12): 1450-1458.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1365-3156.2007.01951.x
